Literature DB >> 25482235

A second-generation Bacillus cell factory for rare inositol production.

Kosei Tanaka1, Shinji Takanaka, Ken-ichi Yoshida.   

Abstract

Some rare inositol stereoisomers are known to exert specific health-promoting effects, including scyllo-inositol (SI), which is a promising therapeutic agent for Alzheimer disease. We recently reported a Bacillus subtilis cell factory that performed the efficient production of SI from the cheapest and most abundant isomer myo-inositol (MI). In the cell factory all "useless" genes involved in MI and SI metabolism were deleted and overexpression of the key enzymes, IolG and IolW, was appended. It converted 10 g/L MI into the same amount of SI in 48 h of cultivation. In this addendum, we discuss further improvement in the cell factory and its possible applications.

Entities:  

Keywords:  Alzheimer disease; Bacillus subtilis; bioconversion; myo-inositol; scyllo-inositol

Mesh:

Substances:

Year:  2014        PMID: 25482235      PMCID: PMC4156495          DOI: 10.4161/bioe.29897

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  21 in total

1.  Differential substrate specificity of two inositol transporters of Bacillus subtilis.

Authors:  Tetsuro Morinaga; Takatsugu Matsuse; Hitoshi Ashida; Ken-ichi Yoshida
Journal:  Biosci Biotechnol Biochem       Date:  2010-06-07       Impact factor: 2.043

2.  A new simple method to introduce marker-free deletions in the Bacillus subtilis genome.

Authors:  Takuya Morimoto; Katsutoshi Ara; Katsuya Ozaki; Naotake Ogasawara
Journal:  Genes Genet Syst       Date:  2009-08       Impact factor: 1.517

Review 3.  The phosphoenolpyruvate:sugar phosphotransferase system in gram-positive bacteria: properties, mechanism, and regulation.

Authors:  J Reizer; M H Saier; J Deutscher; F Grenier; J Thompson; W Hengstenberg
Journal:  Crit Rev Microbiol       Date:  1988       Impact factor: 7.624

4.  YtsJ has the major physiological role of the four paralogous malic enzyme isoforms in Bacillus subtilis.

Authors:  Guillaume Lerondel; Thierry Doan; Nicola Zamboni; Uwe Sauer; Stéphane Aymerich
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

5.  Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

Authors:  JoAnne McLaurin; Meredith E Kierstead; Mary E Brown; Cheryl A Hawkes; Mark H L Lambermon; Amie L Phinney; Audrey A Darabie; Julian E Cousins; Janet E French; Melissa F Lan; Fusheng Chen; Sydney S N Wong; Howard T J Mount; Paul E Fraser; David Westaway; Peter St George-Hyslop
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

6.  Specificity of mood stabilizer action on neuronal growth cones.

Authors:  Galit Shaltiel; Emma C Dalton; Robert H Belmaker; Adrian J Harwood; Galila Agam
Journal:  Bipolar Disord       Date:  2007-05       Impact factor: 6.744

7.  Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis.

Authors:  Tetsuro Morinaga; Hitoshi Ashida; Ken-ichi Yoshida
Journal:  Microbiology       Date:  2010-02-04       Impact factor: 2.777

8.  The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence.

Authors:  Farahnaz Movahedzadeh; Debbie A Smith; Richard A Norman; Premkumar Dinadayala; Judith Murray-Rust; David G Russell; Sharon L Kendall; Stuart C G Rison; Mark S B McAlister; Gregory J Bancroft; Neil Q McDonald; Mamadou Daffe; Yossef Av-Gay; Neil G Stoker
Journal:  Mol Microbiol       Date:  2004-02       Impact factor: 3.501

9.  myo-Inositol catabolism in Bacillus subtilis.

Authors:  Ken-ichi Yoshida; Masanori Yamaguchi; Tetsuro Morinaga; Masaki Kinehara; Maya Ikeuchi; Hitoshi Ashida; Yasutaro Fujita
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

10.  Complete hydrolysis of myo-inositol hexakisphosphate by a novel phytase from Debaryomyces castellii CBS 2923.

Authors:  Mélanie Ragon; André Aumelas; Patrick Chemardin; Santiago Galvez; Guy Moulin; Hélène Boze
Journal:  Appl Microbiol Biotechnol       Date:  2007-11-29       Impact factor: 4.813

View more
  6 in total

Review 1.  Recent Advances in the Physiology of Spore Formation for Bacillus Probiotic Production.

Authors:  Vladimir Elisashvili; Eva Kachlishvili; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

Review 2.  Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives.

Authors:  Fouad M F Elshaghabee; Namita Rokana; Rohini D Gulhane; Chetan Sharma; Harsh Panwar
Journal:  Front Microbiol       Date:  2017-08-10       Impact factor: 5.640

3.  Efficient production of myo-inositol in Escherichia coli through metabolic engineering.

Authors:  Ran You; Lei Wang; Congrong Shi; Hao Chen; Shasha Zhang; Meirong Hu; Yong Tao
Journal:  Microb Cell Fact       Date:  2020-05-24       Impact factor: 5.328

4.  Identification of Bacillus species: Implication on the quality of probiotic formulations.

Authors:  Francesco Celandroni; Alessandra Vecchione; Alice Cara; Diletta Mazzantini; Antonella Lupetti; Emilia Ghelardi
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

5.  A bacterial cell factory converting glucose into scyllo-inositol, a therapeutic agent for Alzheimer's disease.

Authors:  Christophe Michon; Choong-Min Kang; Sophia Karpenko; Kosei Tanaka; Shu Ishikawa; Ken-Ichi Yoshida
Journal:  Commun Biol       Date:  2020-03-02

Review 6.  Bacillus spp. Probiotic Strains as a Potential Tool for Limiting the Use of Antibiotics, and Improving the Growth and Health of Pigs and Chickens.

Authors:  Diana Luise; Paolo Bosi; Lena Raff; Laura Amatucci; Sara Virdis; Paolo Trevisi
Journal:  Front Microbiol       Date:  2022-02-07       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.